Levi Garraway
Harvard University
H-index: 138
North America-United States
Top articles of Levi Garraway
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Compositions and methods for treating ovarian tumors | 2020/12/17 | ||
C-RAF Mutants that Confer Resistance to RAF Inhibitors | 2023/10/17 | ||
MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors | 2023/10/17 | ||
Author Correction: Pan-cancer analysis of whole genomes | Nature | 2023/2/16 | |
Abstract C070: REAL variance in genomic testing by sex, age, race, ethnicity, and language: PROFILE database 7/2011-1/2022 | Nadine Jackson McCleary Ellana K Haakenstad Bridget Neville Arrien A Bertram Wendy Loeser | 2023/1/1 | |
Author Correction: The evolutionary history of 2,658 cancers (Nature,(2020), 578, 7793,(122-128), 10.1038/s41586-019-1907-7) | Nature | Moritz Gerstung Clemency Jolly Ignaty Leshchiner Stefan C Dentro Santiago Gonzalez | 2023/2/16 |
Highly multiplexed, image-based pooled screens in primary cells and tissues with PerturbView | bioRxiv | Takamasa Kudo Ana M Meireles Reuben Moncada Yushu Chen Ping Wu | 2023 |
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing | Nature genetics | Isidro Cortés-Ciriano Jake June-Koo Lee Ruibin Xi Dhawal Jain Youngsook L Jung | 2023/6 |
A compendium of Amplification-Related Gain Of Sensitivity (ARGOS) genes in human cancer | bioRxiv | Veronica Rendo Michael Schubert Nicholas Khuu Maria F Suarez Peredo Rodriguez Kaimeng Huang | 2023 |
Persistent patient barriers to genomic testing in ambulatory oncology | Cancer Research | Ellana K Haakenstad Jane Roberts Anna C Revette Wendy Loeser Joseph Grider | 2023/4/4 |
Methods of identifying responses to map kinase inhibition therapy | 2022/5/5 | ||
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma | Clinical Cancer Research | Caitlin A Creasy Yuzhong Jeff Meng Marie-Andrée Forget Tatiana Karpinets Katarzyna Tomczak | 2022/5/2 |
Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment | Science | Eran Hodis Elena Torlai Triglia John YH Kwon Tommaso Biancalani Labib R Zakka | 2022/4/29 |
037 A systems immunology approach to classify melanoma tumor infiltrating lymphocytes (TILs) informs and models overall survival | Journal of Investigative Dermatology | A Jaiswal A Verma R Dannenfelser M Melssen I Tirosh | 2022/8/1 |
Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples | The Prostate | Elizabeth H Stover Coyin Oh Paula Keskula Atish D Choudhury Yuen‐Yi Tseng | 2022/4 |
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes | Cancer cell | Abhinav Jaiswal Akanksha Verma Ruth Dannenfelser Marit Melssen Itay Tirosh | 2022/5/9 |
Medical uses involving c-raf mutants that confer resistance to raf inhibitors | 2022/1/5 | ||
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses | Science translational medicine | Jennifer A Lo Masayoshi Kawakubo Vikram R Juneja Mack Y Su Tal H Erlich | 2021/2/17 |
Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy | 2021/12/30 | ||
ERK1 and ERK2 mutations that confer resistance to MAPK pathway inhibitors | 2021/11/30 |
